Sionna Therapeutics (SION) Misses Q2 EPS by 14c

Sionna Therapeutics (NASDAQ: SION) reported Q2 EPS of ($0.66), $0.14 worse than the analyst estimate of ($0.52).

For earnings history and earnings-related data on Sionna Therapeutics (SION) click here.

You May Also Be Interested In

• Calumet Specialty Products Partners (CLMT) PT Raised to $47 at UBS
• UBS Reiterates Buy Rating on PG&E Corporation (PCG)
• Snowflake Inc. (SNOW) PT Raised to $360 at Benchmark Into Q2 Earnings